Effects of dextrorotatory morphinans on brain Na+ channels expressed in Xenopus oocytes

European Journal of Pharmacology

Volumn 564, Issue 1-3, 2007, Pages 7-17

  Lee, Jun Ho ^a   Shin, Eun Joo ^b   Jeong, Sang Min ^a   Lee, Byung Hwan ^a   Yoon, In Soo ^a   Lee, Jun Hee ^a   Choi, Sun Hye ^a   Kim, Yun Hi ^a   Pyo, Mi Kyung ^a   Lee, Sang Mok ^a   Chae, Jong Seok ^b   Rhim, Hyewhon ^c   Oh, Jae Wook ^d   Kim, Hyoung Chun ^b   Nah, Seung Yeol ^e  

^a Konkuk University School of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Chosun University   (South Korea)

^e NONE

Author keywords

Brain Na+ channel; Dextromethorphan; Dextromethorphan analog; Xenopus oocyte

Indexed keywords

3 ALLYLOXY 17 METHOXYMORPHINAN; 3 CYCLOPROPYL 17 METHOXYMORPHINAN; 3 METHOXYMORPHINAN; 3 METHYL 17 METHYLMORPHINAN; DEXTROMETHORPHAN; MORPHINAN DERIVATIVE; SODIUM CHANNEL; SODIUM CHANNEL NAV1.2 ALPHA; SODIUM CHANNEL NAV1.2 BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; IC 50; MEMBRANE POTENTIAL; MICROELECTRODE; NEUROPROTECTION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CURRENT; VOLTAGE CLAMP; XENOPUS;

ANIMALS; BRAIN; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GENE EXPRESSION; MEMBRANE POTENTIALS; MICROELECTRODES; NEUROPROTECTIVE AGENTS; OOCYTES; PROTEIN SUBUNITS; RATS; RNA, COMPLEMENTARY; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 34250693118     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.088     Document Type: Article

References (35)

1. Bean B.P., Cohen C.J., and Tsien R.W. Lidocaine block of cardiac sodium channels. J. Gen. Physiol. 81 (1983) 613-642
2. Catterall W.A. Identification of an alpha subunit of dihydropyridine-sensitive brain calcium channels. Trends Pharmacol. Sci. 8 (1987) 57-65
3. Cestele S., and Catterall W.A. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochime 82 (2000) 883-892
4. Choi D.W. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res. 403 (1987) 333-336
5. Damaj M.I., Flod P., Ho K.K., May E.L., and Martin R.B. Effect of dextromethorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J. Pharmacol. Exp. Ther. 312 (2005) 780-785
6. Dascal N. The use of Xenopus oocytes for the study of ion channels. CRC Crit. Rev. Biochem. 22 (1987) 317-387
7. Elliott K., Hynansky A., and Inturrisi C.E. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59 (1994) 361-368
8. + channels. In: North R.A. (Ed). Ligand- and voltage-gated ion channels (1995), CRC Press, Boca Raton, FL 73-89
9. Hodgkin A.L., and Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (London) 117 (1952) 500-544
10. Hondegham L.M., and Kazung B.G. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu. Rev. Pharmacol. Toxicol. 24 (1984) 387-423
11. Jhoo W.K., Shin E.J., Lee Y.H., Cheon M.A., Oh K.W., Kang S.Y., Lee C., Yi B.C., and Kim H.C. Dual effects of dextromethorphan on cocaine-induced conditioned place preference in mice. Neurosci. Lett. 288 (2000) 76-80
12. 3 action on ion channels. Mol. Cells 18 (2004) 383-389
13. + channel inhibition. Mol. Cells 19 (2005) 137-142
14. Kim H.C., Ko K.H., Kim W.K., Shin E.J., Kang K.S., Shin C.Y., and Jhoo W.K. Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan. Behav. Brain Res. 120 (2001) 169-175
15. Kim H.C., Nabeshima T., Jhoo W.K., Ko K.H., Kim W.K., Shin E.J., Cho M., and Lee P.H. Anticonvulsant effects of new morphinan derivatives. Bioorg. Med. Chem. Lett. 11 (2001) 1651-1654
16. Kim H.C., Pennypacker K., Bing G., Bronstein D., McMillian M., and Hong J.S. The effect of dextromethorphan on kainic acid-induced seizures in the rat. Neurotoxicology 17 (1996) 375-386
17. Kim H.C., Shin C.Y., Seo D.O., Jhoo J.H., Jhoo W.K., Kim W.K., Shin E.J., Lee Y.H., Lee P.H., and Ko K.H. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice. Life Sci. 72 (2003) 1883-1895
18. 2+. Voltage and concentration dependence of calcium entry into the pore. J. Gen. Physiol. 88 (1986) 321-347
19. Lenkowski P.W., Shah B.S., Dinn A.E., Lee K., and Patel M.K. Lidocaine block of neuronal Nav1.3 is differentially modulated by co-expression of b1 and b3 subunits. Eur. J. Pharmacol. 467 (2003) 23-30
20. Liu Y., Qin L., Li G., Zhang W., An L., Liu B., and Hong J.S. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J. Pharmacol. Exp. Ther. 305 (2003) 212-218
21. + current inhibition. Mol. Pharmacol. 68 (2005) 1114-1126
22. Mao J., Price D.D., Caruso F.S., and Mayer D.J. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 67 (1996) 361-368
23. Netzer R., Pflimlin P., and Trube G. Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur. J. Pharmacol. 238 2-3 (1993) 209-216
24. + channels. Eur. J. Pharmacol. 343 (1998) 93-104
25. Pugsley M.K., Yu E.J., and Goldin A.L. Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes. Gen. Pharmacol. 34 (2000) 417-427
26. Price D.P., Mao J., Lu J., Caruso F.S., Frenk H., and Mayer D.J. Effects of combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain 68 (1996) 119-126
27. Ragsdale D.S., and Avoli M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Brain Res. Rev. 26 (1998) 16-28
28. Shin E.J., Nabeshima T., Lee P.H., Kim W.K., Ko K.H., Jhoo J.H., Jhoo W.K., Cha J.Y., and Kim H.C. Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice. Behav. Brain Res. 151 (2004) 267-276
29. Stuart G.J., and Sakmann B. Active propagation of somatic action potentials into neocortical pyramidal cell dendrites. Nature 367 (1994) 60-72
30. Trube G., and Netzer R. Dextromethorphan: cellular effects reducing neuronal hyperactivity. Epilepsia 35 (1994) S62-S67
31. Wang S.H., and Wang G.K. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell. Signal. 15 (2003) 151-159
32. + channel inactivation. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10910-10914
33. Willow M., Gonoi T., and Catterall W.A. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol. Pharmacol. 27 (1985) 549-558
34. Yin K.J., and Sun F.Y. Effect of dextromethorphan, a NMDA antagonist, on DNA repair in rat photochemical thrombotic cerebral ischemia. Brain Res. 815 (1999) 29-35
35. Yu F.H., Westenbroek R.E., Silos-Santiago I., McCormick K.A., Lawson D., Ge F., Ferriera H., Lilly J., DiStefano P.S., Catterall W.A., Scheuer T., and Curtis R. Sodium channel β4, a new disulfide-linked auxiliary subunit with similarity to β2. J. Neurosci. 23 (2003) 7577-7585